Skip to content

EF Pharma

Open bankruptcy
Private limited company (pre-2019)founded 2015KBO/BCE: BE 0588.990.037

A bankruptcy procedure is open for EF Pharma according to publications in the Belgian State Gazette; curator: THOMAS VANDENDRIES. The file additionally contains 2 judicial reorganisations. The 2020 annual accounts show negative equity (€-283k) and a net result of €-92k.

Signals

Four signals. The signal on the left, the evidence on the right.
+raises riskneutral
raises risk · Register: open bankruptcy
The KBO register records the legal situation: open bankruptcy (code 050). This is today's state according to the register itself; the register carries no start date.
KBO · legal situation
raises risk · Open bankruptcy
Active bankruptcy procedure in the Belgisch Staatsblad. Claims are handled by the appointed curator.
Belgian State Gazette
neutral · Filed after the deadline
The financial year that closed on 31-12-2020 was due by 31-07-2021 and was filed on 28-09-2021, 59 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filings
Deviation from the deadline
2025
not confirmed
2024
not filed
2023
not filed
2022
not filed
2021
not filed
2020
59 d late
2019
90 d late
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2020, abbreviated schema

Equity
€-283k▼ 49.1%
2019 · €-190k
2018: €-167k 2019: €-190k
2018 → 2020
Total assets
€487k▲ 22.1%
2019 · €398k
2018: €90k 2019: €398k
2018 → 2020
Net result
€-92k▼ 299%
2019 · €-23k
2018: €-28k 2019: €-23k
2018 → 2020
Working capital
€-153k▲ 41.1%
2019 · €-260k
2018: €-138k 2019: €-260k
2018 → 2020
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line201820192020Trend
Equity€-167k-€-190k▼ 13.9%€-283k▼ 49.1%
Operating result€-25k-€-97k▼ 291%€-84k▲ 13.0%
Net result€-28k-€-23k▲ 17.6%€-92k▼ 299%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-100k€-75k€-50k€-25k€0Operating result 2018: €-25k€-25kNet result 2018: €-28k€-28kOperating result 2019: €-97k€-97kNet result 2019: €-23k€-23kOperating result 2020: €-84k€-84kNet result 2020: €-92k€-92k201820192020
The operating result stays negative: a loss of €84k in 2020 against €97k in 2019; the loss shrinks.
Balance-sheet composition
2020 in colour, 2019 as the grey bar beneath
Assets €487k
Fixed assets €213k▲ 8.6%
Current assets €273k▲ 35.3%
Key figures and ratios
2020 value · change against 2019
EBITDA
€-54k
2019 · €-52k
Cash flow
€-62k
2019 · €22k
Solvency
-58.2%
2019 · -47.7%
Current ratio
0.64
2019 · 0.44
Quick ratio
0.42
2019 · 0.26
Debt / equity
-1.10
2019 · -0.67
ROA
-19.0%
2019 · -5.8%
Debt
€770k
2019 · €588k
Debt ≤ 1 year
€426k
2019 · €462k
Debt > 1 year
€310k
2019 · €126k
Income taxes
€1k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2020 against 2019
Balance sheet Code20192020
Assets
Total assets20/58€398k€487k
Fixed assets21/28€197k€213k
Tangible fixed assets22/27€196k€171k
Financial fixed assets28€289€42k
Current assets29/58€202k€273k
Stocks and contracts in progress3€84k€93k
Amounts receivable within one year40/41€106k€179k
Current investments50/53€1k-
Cash at bank and in hand54/58€2k€262
Equity and liabilities
Total equity and liabilities10/49€398k€487k
Equity10/15€-190k€-283k
Contributions10/11€12k-
Profit (loss) carried forward14€-202k€-295k
Amounts payable17/49€588k€770k
Amounts payable after more than one year17€126k€310k
Amounts payable within one year42/48€462k€426k
Trade debts44€139k€168k
Income statement Code20192020
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€45k€31k
Gross operating margin9900€-38k€-35k
Operating profit (loss)9901€-97k€-84k
Recurring financial income75-€1
Recurring financial charges65€3k€7k
Profit (loss) for the period before taxes9903€-23k€-91k
Income taxes67/77-€1k
Profit (loss) for the period9904€-23k€-92k
Profit (loss) for the period to be appropriated9905€-23k€-92k

Download as CSV

Timeline · acts, filings and financial milestones

2021
19-10
Bankruptcy Opening
Ondernemingsrechtbank Brussel · EF PHARMA BV IKAROS- LAAN 1, 1930 ZAVENTEM · event 12-10-2021
28-09
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 59 days late
25-06
Judicial reorganisation Opening
ondernemingsrechtbank Brussel · amiable · event 14-06-2021
21-06
Judicial reorganisation Opening
ondernemingsrechtbank Brussel · amiable · event 14-06-2021
2020
31-12
Financial Weakest financial yearnet €-92k
Net result drops to €-92k, the lowest in the series.
29-10
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 90 days late
2019
30-09
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 61 days late
2018
23-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 23 days late
2017
31-08
NBB filing Annual accounts filed
fiscal year 2016 · micro schema · 31 days late
2016
26-08
NBB filing Annual accounts filed
fiscal year 2015 · full schema · 26 days late
SignalFinancial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
7 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
1 establishment unit since 2015
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Ground area
5,421 m²
Building footprint
499 m²
Parcel 23772B0101/00B000, Flanders. Linked by address, not a title deed.
1 establishment unit
Par Isis
Retail sale of pharmaceutical products
since 20152.298.550.503
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23772B0101/00B000 Flanders 5,421 m² 1 · 499 m² -
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Insolvency mandates

1 mandate
Role Name Tenure
Curator THOMAS VANDENDRIES
STEENWEG OP SINT JORIS WINGE 21, 3200 AARSCHOT
12-10-2021 → present

Similar companies · same sector, comparable size

Of 13,422 companies in sector 73300 we hold annual accounts for 6,901. 3,582 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company (pre-2019)
Founded29-01-2015
Fiscal year end31-12
Activities, NACEBEL
70210Activities of head offices; management consultancy activities
73300Public relations and communication consultancy
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.